This legislation, known as the SBIR/STTR Pilot Extension Act , aims to extend and expand several critical pilot programs under the Small Business Act. Specifically, it extends the "Direct to Phase II" authority from 2025 to 2030 , allowing small businesses to bypass Phase I and proceed directly to Phase II research and development. This authority is also expanded from a few specific agencies to all Federal agencies required to carry out an SBIR program. The bill establishes new funding limitations for the "Direct to Phase II" authority, generally capping awards at 10 percent of an agency's total SBIR funds, with the National Institutes of Health permitted up to 15 percent . Agencies utilizing this authority will be required to report on the number and amount of awards provided. Furthermore, the bill extends the Commercialization Readiness Program for civilian agencies, the Phase 0 Proof of Concept Partnership Program, and Commercialization Assistance Pilot Programs until September 30, 2030 , ensuring continued support for small business innovation and commercialization efforts.